Identifying disease modifying genes in multiple sclerosis

被引:100
作者
Kantarci, OH
de Andrade, M
Weinshenker, BG
机构
[1] Mayo Clin & Mayo Fdn, Dept Neurol, Rochester, MN 55905 USA
[2] Mayo Clin & Mayo Fdn, Dept Hlth Sci Res, Rochester, MN 55905 USA
关键词
multiple sclerosis; genetics; prognosis; severity; course; outcome;
D O I
10.1016/S0165-5728(01)00481-7
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Evidence is mounting that genetic variation influences not only susceptibility to multiple sclerosis (MS), but also its course and severity. Identification of disease modifying genes, however, poses unique challenges, especially on how to classify the course and outcome of the disease in ways that may be relevant to analysis of biological factors that might be influenced by genes, The power of the statistical approaches to detect small effects of individual genes in complex disorders such as MS is problematic, and approaches to estimate power must be appropriate for the data. Nonetheless, using contemporary schemes of classification, genetic variants that influence disease course have been found; in fact, a small number have been confirmed to influence disease course in two or more independent studies. This review addresses strategies relevant to identification of disease modifying genes in MS, and summarizes and critically evaluates the cur-rent state of knowledge in this area. (C) 2002 Elsevier Science B.V All rights reserved.
引用
收藏
页码:144 / 159
页数:16
相关论文
共 139 条
  • [121] Pathology and pathogenesis of demyelinating diseases
    Storch, M
    Lassmann, H
    [J]. CURRENT OPINION IN NEUROLOGY, 1997, 10 (03) : 186 - 192
  • [122] Teller K, 1996, J RHEUMATOL, V23, P1363
  • [123] Occurrence and clinical relevance of an interleukin-4 gene polymorphism in patients with multiple sclerosis
    Vandenbroeck, K
    Martino, G
    Marrosu, MG
    Consiglio, A
    Zaffaroni, M
    Vaccargiu, S
    Franciotta, D
    Ruggeri, M
    Comi, G
    Grimaldi, LME
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 1997, 76 (1-2) : 189 - 192
  • [124] ASSOCIATION OF HLA-DR4 WITH A MORE PROGRESSIVE DISEASE COURSE IN PATIENTS WITH RHEUMATOID-ARTHRITIS - RESULTS OF A FOLLOW-UP-STUDY
    VANZEBEN, D
    HAZES, JMW
    ZWINDERMAN, AH
    CATS, A
    SCHREUDER, GMT
    DAMARO, J
    BREEDVELD, FC
    [J]. ARTHRITIS AND RHEUMATISM, 1991, 34 (07): : 822 - 830
  • [125] Wakitani S, 1997, BRIT J RHEUMATOL, V36, P630
  • [126] Polymorphisms of apolipoprotein E; outcome and susceptibility in multiple sclerosis
    Weatherby, SJM
    Mann, CLA
    Davies, MB
    Carthy, D
    Fryer, AA
    Boggild, MD
    Young, C
    Strange, RC
    Ollier, W
    Hawkins, CP
    [J]. MULTIPLE SCLEROSIS, 2000, 6 (01): : 32 - 36
  • [127] Weatherby SJM, 2000, J NEUROL NEUROSUR PS, V68, P532, DOI 10.1136/jnnp.68.4.532
  • [128] THE NATURAL-HISTORY OF MULTIPLE-SCLEROSIS
    WEINSHENKER, BG
    [J]. NEUROLOGIC CLINICS, 1995, 13 (01) : 119 - 146
  • [129] Major histocompatibility complex class II alleles and the course and outcome of MS - A population-based study
    Weinshenker, BG
    Santrach, P
    Bissonet, AS
    McDonnell, SK
    Schaid, D
    Moore, SB
    Rodriguez, M
    [J]. NEUROLOGY, 1998, 51 (03) : 742 - 747
  • [130] Genetic variation in the B7-1 gene in patients with multiple sclerosis
    Weinshenker, BG
    Hebrink, DD
    Klein, C
    Atkinson, EJ
    O'Brien, PC
    McMurray, CT
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 2000, 105 (02) : 184 - 188